Saremi et al. found PPARγ2 (c.34G>C, Pro12Ala) is considerably associated with higher risk NAFLD [9] in T2DM patients in Iranian population. This evidence concerns the gene PPARG and metabolic dysfunction-associated steatotic liver disease.